chr7-21616294-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PVS1_ModeratePP5
The NM_001277115.2(DNAH11):c.4095+2C>T variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000628 in 1,608,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001277115.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151918Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000130 AC: 32AN: 246968 AF XY: 0.000149 show subpopulations
GnomAD4 exome AF: 0.0000625 AC: 91AN: 1456826Hom.: 0 Cov.: 29 AF XY: 0.0000925 AC XY: 67AN XY: 724692 show subpopulations
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74272 show subpopulations
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 7 Pathogenic:1Uncertain:1
The c.4095+2C>T variant in DNAH11 has not been previously reported in the literature in individuals with primary ciliary dyskinesia, but has been identified in 0.1% (88/90234) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs532007878). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID: 2571275) and has been interpreted as likely pathogenic by CeGaT Center for Human Genetics Tuebingen. This variant is located in the 3' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine out pathogenicity. Loss of function of the DNAH11 gene is an established disease mechanism in autosomal recessive primary ciliary dyskinesia. In summary, the clinical significance of the c.4095+2C>T variant is uncertain. ACMG/AMP Criteria applied: PVS1_strong (Richards 2015). -
Variant summary: DNAH11 c.4095+2C>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing and loss of DNAH11 function. Several computational tools predict a significant impact on normal splicing: Three predict the variant creates a 5' donor site. One predict the variant strengthens a 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00013 in 246968 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in DNAH11 causing Primary Ciliary Dyskinesia 7, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.4095+2C>T in individuals affected with Primary Ciliary Dyskinesia 7 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2571275). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
DNAH11: PVS1:Strong, PM2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at